ArticleOncology reports2021

An anti‑TROP2 monoclonal antibody TrMab‑6 exerts antitumor activity in breast cancer mouse xenograft models.

Tomohiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.